|Table of Contents|

Correlation and research progress of autophagy and chemotherapy resistance of tumor

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 17
Page:
3314-3318
Research Field:
Publishing date:

Info

Title:
Correlation and research progress of autophagy and chemotherapy resistance of tumor
Author(s):
LIU MingdongZHU Jinhong
Department of Oncology,Harbin Medical University Cancer Hospital,Heilongjiang Harbin 150081,China.
Keywords:
autophagychemotherapydrug resistancecancer
PACS:
R730.53
DOI:
10.3969/j.issn.1672-4992.2023.17.032
Abstract:
Autophagy is a self-degrading cellular process,which is mainly responsible for degrading dysfunctional or unnecessary proteins and organelles to maintain cell homeostasis.In recent years,the relationship between tumors and autophagy has been paid much attention.More and more evidences show that autophagy has a paradoxical role in tumor development and treatment.Chemotherapy is currently one of the most effective methods for the treatment of cancer,together with surgery and radiotherapy,it is called the three major treatment methods for cancer.However,the acquired drug resistance produced during chemotherapy has become the primary reason for tumor treatment failure.Studies have shown that autophagy is one of the key processes of tumor chemotherapy resistance.This article reviews the correlation and research progress of autophagy and tumor chemotherapy resistance.

References:

[1]CHOW LQM.Head and neck cancer[J].New England Journal of Medicine,2020,382(1):60-72.
[2]LIN TY,CHAN HH,CHEN SH,et al.BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells[J].Autophagy,2020,16(7):1296-1313.
[3]NEW J,THOMAS SM.Autophagy-dependent secretion:mechanism,factors secreted,and disease implications[J].Autophagy,2019,15(10):1682-1693.
[4]LI YU,YANG CHEN,SHARON A,et al.Autophagy pathway:Cellular and molecular mechanisms[J].Autophagy,2018,14(2):207-215.
[5]YOOMI,CHUN,JOUNGMOK,et al.Autophagy:An essential degradation program for cellular homeostasis and life[J/OL].Cells,(2018-12-19)[2020-07-04].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315530/.DOI: 10.3390/cells7120278.
[6]YORIMITSU T,KLIONSKY DJ.Autophagy:molecular machinery for self-eating [J].Cell Death Differ,2005,12(Suppl 2):1542-1552.
[7]WIRAWAN E,VANDEN BERGHE T,LIPPENS S,et al.Autophagy:for better or for worse [J].Cell Res,2012,22(1):43-61.
[8]FALZONE L,SALOMONE S,LIBRA M.Evolution of cancer pharmacological treatments at the turn of the third millennium [J].Front Pharmacol,2018,9 :1300.
[9]KENTA M,BEATRICE G,JILL W,et al.A tale of two approaches:complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments [J].Carcinogenesis,2013,34(4):725-738.
[10]MARTA PREZ-HERNNDEZ,ARIAS A,DAVID MARTNEZ-GARCA,et al.Targeting autophagy for cancer treatment and tumor chemosensitization[J].Cancers,2019,11(10):1599.
[11]LEVY JMM,TOWERS CG,THORBURN A.Targeting autophagy in cancer[J].Nat Rev Cancer,2017,17(9):528-542.
[12]LI X,ZHOU Y,LI Y,et al.Autophagy:A novel mechanism of chemoresistance in cancers[J/OL].Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,(2019-11-01)[2020-07-06].https://doi.org/10.1016/j.biopha.2019.109415.
[13]YANG Z,KLIONSKY DJ.Mammalian autophagy:core molecular machinery and signaling regulation [J].Curr Opin Cell Biol,2009,22(2):124-131.
[14]FAN Z,HUANGFU X,LIU Z.Effect of autophagy on cisplatin-induced bladder cancer cell apoptosis.[ J].Panminerva Med,2017,59(1):1-8.
[15]FREDDIE,BRAY,JACQUES,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:a Cancer Journal for Clinicians,2018,68(6):394-424.
[16]LEE JG,SHIN JH,SHIM HS,et al.Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions[J].Respiratory Research,2015,16:138.
[17]DATTA S,CHOUDHURY D,DAS A,et al.Autophagy inhibition with chloroquine reverts paclitaxel resistance and attenuates metastatic potential in human nonsmall lung adenocarcinoma A549 cells via ROS mediated modulation of β-catenin pathway [J].Apoptosis An International Journal on Programmed Cell Death,2019,24(5-6):414-433.
[18]SHI S,TAN P,YAN B,et al.ER stress and autophagy are involved in the apoptosis induced by cisplatin in human lung cancer cells[J].Oncology Reports,2016,35(5):2606-2614.
[19]WU HM,SHAO LJ,JIANG ZF,et al.Gemcitabine-induced autophagy protects human lung cancer cells from apoptotic death [J].Lung,2016,194(6):1-8.
[20]ENDO S,UCHIBORI M,SUYAMA M,et al.Novel Atg4B inhibitors potentiate cisplatin therapy in lung cancer cells through blockade of autophagy [J/OL].Computational Toxicology,(2019-11-01)[2020-07-06].https://doi.org/10.1016/j.comtox.2019.100095.
[21]WANG H,CHEN J,ZHANG S,et al.miR-223 regulates autophagy associated with cisplatin resistance by targeting FBXW7 in human non-small cell lung cancer [J/OL].Cancer Cell Int,(2020-06-19)[2020-07-08].https://doi.org/10.1186/s12935-020-01284-x.
[22]ZHAO L,WU X,ZANG Z,et al.ELF1 suppresses autophagy to reduce cisplatin resistance via the miR-152-3p/NCAM1/ERK axis in lung cancer cells[J].Cancer Sci,2023,114(6):2650-2663.
[23]PAN ST,ZHOU J,YANG F,et al.Proteomics reveals a therapeutic vulnerability via the combined blockade of APE1 and autophagy in lung cancer A549 cells [J/OL].BMC Cancer,(2020-07-08)[2020-07-12].https://doi.org/10.1186/s12885-020-07111-w.
[24]WEIN L,LOI S.Mechanisms of resistance of chemotherapy in early-stage triple negative breast cancer(TNBC)[J].The Breast,2017,34(Suppl 1):S27-S30.
[25]DAS CK,LINDER B,BONN F,et al.BAG3 overexpression and cytoprotective autophagy mediate apoptosis resistance in chemoresistant breast cancer cells[J].Neoplasia,2018,20(3):263-279.
[26]LIU Z,SHI A,SONG D,et al.Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction[J].American Journal of Cancer Research,2017,7(3):574-583.
[27]ZHANG LH,YANG AJ,WANG M,et al.Enhanced autophagy reveals vulnerability of P-gp mediated epirubicin resistance in triple negative breast cancer cells[J].Apoptosis,2016,21(4):473-488.
[28]LIN HY,KUEI CH,LEE HH,et al.TNFSF13 upregulation confers chemotherapeutic resistance via triggering autophagy initiation in triple-negative breast cancer[J].Journal of Molecular Medicine,2020,98(9):1255-1267.
[29]ZHANG P,LIU X,LI H,et al.TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathway[J/OL].Sci Rep,(2017-06-09)[2020-07-10].https://doi.org/10.1038/s41598-017-03230-w.
[30]LIU B,QI X,ZHANG X,et al.Med19 is involved in chemoresistance by mediating autophagy through HMGB1 in breast cancer[J].Journal of Cellular Biochemistry,2019,120(1):507-518.
[31]DING LY,CHU M,JIAO YS,et al.TFDP3 regulates the apoptosis and autophagy in breast cancer cell line MDA-MB-231[J/OL].PLoS One,(2018-09-20)[2020-07-08].https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0203833.DOI:10.1371/journal.pone.0203833.
[32]TANG ZN,BI XF,CHEN WL,et al.RANKL promotes chemotherapy resistance in breast cancer cells through STAT3 mediated autophagy induction[J].Clin Breast Cancer,2023,23:388-396.
[33]PEDRO J,TRRAGA LPEZ,JUAN SOLERA,et al.Primary and secondary prevention of colorectal cancer [J/OL].Clin Med Insights Gastroenterol,(2014-07-14)[2020-07-07].https://journals.sagepub.com/doi/full/10.4137/CGast.S14039.
[34]ANDR T,GRAMONT AD.An overview of adjuvant systemic chemotherapy for colon cancer [J].Clinical Colorectal Cancer,2004,4(supp-S1):S22-S28.
[35]SASAKI K,TSUNO NH,SUNAMI E,et al.Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells [J].Bmc Cancer,2010,10(1):370.
[36]RAMIREZ JAZ,ROMAGNOLI GG,FALASCO BF,et al.Blocking drug-induced autophagy with chloroquine in HCT-116 colon cancer cells enhances DC maturation and T cell responses induced by tumor cell lysate [J/OL].International Immunopharmacology,(2020-04-13)[2020-07-10].https://www.sciencedirect.com/science/article/pii/S1567576920306354.
[37]LI J,HOU N,FARIED A,et al.Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model[J].European Journal of Cancer,2010,46(10):1900-1909.
[38]LI J,HOU N,FARIED A,et al.Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells[J].Annals of Surgical Oncology,2009,16(3):761-771.
[39]TAN S,SHI H,BA M,et al.miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy[J].International Journal of Molecular Medicine,2016,37(4):1030-1038.
[40]ZHANG P,LAI ZL,CHEN HF,et al.Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy,AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice[J/OL].Journal of Experimental & Clinical Cancer Research,(2017-12-22)[2020-07-10].https://link.springer.com/article/10.1186/s13046-017-0661-7.DOI:10.1186/s13046-017-0661-7.
[41]CHEN W,ZHENG R,BAADE PD,et al.Cancer statistics in China,2015 [J].CA Cancer J Clin,2016,66(2):115-132.
[42]JASON,M,FARROW,et al.Autophagy as a modulator and target in prostate cancer[J].Nature Reviews Urology,2014,11(9):508-516.
[43]JIANG,PEIDU,MIZUSHIMA,et al.LC3- and p62-based biochemical methods for the analysis of autophagy progression in mammalian cells[J].Methods,2015,75:13-18.
[44]LORENTE J,VELANDIA C,LEAL JA,et al.The interplay between autophagy and tumorigenesis:exploiting autophagy as a means of anticancer therapy[J].Biological Reviews of the Cambridge Philosophical Society,2018,93(1):152-165.
[45]WANG Q,HE WY,ZENG YZ,et al.Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells[J].International Urology & Nephrology,2018,50(4):675-686.
[46]PICKARD RD,SPENCER BH,MCFARLAND AJ,et al.Paradoxical effects of the autophagy inhibitor 3-methyladenine on docetaxel-induced toxicity in PC-3 and LNCaP prostate cancer cells[J].Naunyn-Schmiedeberg's Archives of Pharmacology,2015,388(7):793-799.
[47]ZHANG Y,YUAN Y,ZHANG X,et al.HMGB1-mediated autophagy confers resistance to gemcitabine in hormone-independent prostate cancer cells[J].Oncology Letters,2017,14(5):6285-6290.
[48]HU F,ZHAO Y,YU Y,et al.Docetaxel-mediated autophagy promotes chemoresistance in castration-resistant prostate cancer cells by inhibiting STAT3 [J].Cancer Letters,2018,416:24-30.
[49]JIA J,ZHANG HB,SHI Q,et al.KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy[J].Theranostics,2019,9(19):5464-5477.
[50]ZENG J,LIU W,FAN YZ,et al.PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy[J].Theranostics,2018,8(1):109-123.
[51]LIN JZ,WANG WW,HU TT,et al.FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy[J].Cancer Letters,2020,469:481-489.
[52]RICCARDO C,MARINA MM,ELENA CM,et al.Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells[J/OL].Cell Death & Disease,(2018-08-30)[2020-07-11].https://doi.org/10.1038/s41419-018-0866-5.
[53]O' NEILL AJ,PRENCIPE M,DOWLING C,et al.Characterisation and manipulation of docetaxel resistant prostate cancer cell lines[J].Molecular Cancer,2011,10:126.
[54]HANSEN AR,TANNOCK IF,TEMPLETON A,et al.Pantoprazole affecting docetaxel resistance pathways via autophagy(pandora):phase II trial of high dose pantoprazole(autophagy inhibitor) with docetaxel in metastatic castration-resistant prostate cancer(mCRPC)[J].The Oncologist,2019,24(9):1188-1194.
[55]FERNNDEZ MARIO I,MAURIZIO B,CLARK PE,et al.Epidemiology,prevention,screening,diagnosis,and evaluation:update of the ICUD-SIU joint consultation on bladder cancer[J].World Journal of Urology,2019,37(1):3-13.
[56]HUANG X,ZHANG H,YANG X,et al.Activation of a c-Jun N-terminal kinase-mediated autophagy pathway attenuates the anticancer activity of gemcitabine in human bladder cancer cells[J].Anticancer Drugs,2017,28(6):596-602.
[57]LI K,CHEN X,LIU C,et al.Pirarubicin induces an autophagic cytoprotective response through suppression of the mammalian target of rapamycin signaling pathway in human bladder cancer cells[J].Biochem Biophys Res Commun,2015,460(2):380-385.
[58]LIN J,LIN Y,TSAI T,et al.Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells[J].Drug Des Devel Ther,2017,11(8):1517-1533.
[59]YIN L,LIU S,LI C,et al.CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer:the effect is autophagy-associated[J].Tumor Biol,2016,37(9):12731-12742.
[60]WANG YC,TANG Z,ZHANG C,et al.miR-7-5p suppresses invasion via downregulation of the autophagy-related gene ATG7 and increases chemoresistance to cisplatin in BCa[J].Bioengineered,2022,13(3):7328-7339.

Memo

Memo:
-
Last Update: 2023-07-31